KRP-AM1977X PhaseIII Clinical Study-Open-label study for the patients with respiratory tract infection-
Phase of Trial: Phase III
Latest Information Update: 20 Apr 2017
At a glance
- Drugs Lascufloxacin (Primary)
- Indications Respiratory tract infections
- Focus Therapeutic Use
- Sponsors Kyorin Pharmaceutical
- 19 Apr 2017 Status changed from active, no longer recruiting to completed.
- 15 Jun 2016 New trial record
- 12 May 2016 Status changed from recruiting to active, no longer recruiting.